Skip to content
☰ Menu
Open access · US-GOV via ClinicalTrials.gov Clinical trial

Phase II Trial of Rituximab-CHOP (R-CHOP) Plus GM-CSF for Previously Untreated Diffuse Large Cell Lymphoma in the Elderly

Authors not listed

University of Wisconsin, Madison · 2002

Stem-cell exhaustion Human Randomized controlled trial
＋ Sign in to save

Abstract

Patients will receive 6 to 8 cycles of R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone), with GM-CSF.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-19 MST

Cite this

APA
Anonymous. (2002). Phase II Trial of Rituximab-CHOP (R-CHOP) Plus GM-CSF for Previously Untreated Diffuse Large Cell Lymphoma in the Elderly. <em>University of Wisconsin, Madison</em>. https://clinicaltrials.gov/study/NCT00582725
Vancouver
Anonymous. Phase II Trial of Rituximab-CHOP (R-CHOP) Plus GM-CSF for Previously Untreated Diffuse Large Cell Lymphoma in the Elderly. University of Wisconsin, Madison. 2002.
BibTeX
@misc{anon2002PhaseI, title = {Phase II Trial of Rituximab-CHOP (R-CHOP) Plus GM-CSF for Previously Untreated Diffuse Large Cell Lymphoma in the Elderly}, author = {Anonymous}, journal = {University of Wisconsin, Madison}, year = {2002}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings